Symbol="BEAM"
AssetType="Common Stock"
Name="Beam TherapeuticsÂ Inc"
Description="Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1745999"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="26 LANDSDOWNE STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2391705000"
EBITDA="-345700000"
PERatio="None"
PEGRatio="None"
BookValue="10.55"
DividendPerShare="0"
DividendYield="0"
EPS="-4.51"
RevenuePerShareTTM="1.082"
ProfitMargin="0"
OperatingMarginTTM="-4.709"
ReturnOnAssetsTTM="-0.162"
ReturnOnEquityTTM="-0.361"
RevenueTTM="76696000"
GrossProfitTTM="-250674000"
DilutedEPSTTM="-4.51"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.871"
AnalystTargetPrice="66.23"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="32.42"
PriceToBookRatio="4.426"
EVToRevenue="24.39"
EVToEBITDA="-7.47"
Beta="1.575"
num_52WeekHigh="73.27"
num_52WeekLow="28.62"
num_50DayMovingAverage="32.52"
num_200DayMovingAverage="37.9"
SharesOutstanding="76218000"
DividendDate="None"
ExDividendDate="None"
symbol="BEAM"
open="30.39"
high="31.41"
low="30.39"
price="31.38"
volume="851634.00"
latest_trading_day="2023-07-28"
previous_close="29.81"
change="1.57"
change_percent="5.2667%"
aroon_positive_momentum_days="37"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="37"
Volume_recent_avg="897832"
Change_recent_avg="-0.08"
Delta_recent_avg="1.5"
Variance_recent_avg="0.75"
Change_ratio_recent_avg="-0.29"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="37"
Aroon_momentum_negative="63"
image_negative_thumbnail_id_1="505"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0100.jpeg"
image_negative_thumbnail_id_2="1142"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0175.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="607"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0101.jpeg"
image_positive_thumbnail_id_2="989"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0151.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
